Laia Maynou
Laia Maynou
London School of Economics and Political Science, Health Policy // CRES, Universitat Pompeu Fabra
Verified email at - Homepage
TitleCited byYear
Social differences in avoidable mortality between small areas of 15 European cities: an ecological study
R Hoffmann, G Borsboom, M Saez, MM Dell’Olmo, B Burström, D Corman, ...
International journal of health geographics 13 (1), 8, 2014
The impact of structural and cohesion funds on Eurozone convergence, 1990–2010
L Maynou, M Saez, A Kyriacou, J Bacaria
Regional Studies 50 (7), 1127-1139, 2016
Economic crisis and health inequalities: evidence from the European Union
L Maynou, M Saez
International journal for equity in health 15 (1), 135, 2016
Health inequalities in the European Union: an empirical analysis of the dynamics of regional differences
L Maynou, M Saez, J Bacaria, G Lopez-Casasnovas
The European Journal of Health Economics 16 (5), 543-559, 2015
Has the economic crisis widened the intraurban socioeconomic inequalities in mortality? The case of Barcelona, Spain
L Maynou, M Saez, G Lopez-Casasnovas
J Epidemiol Community Health 70 (2), 114-124, 2016
Why do some countries approve a cancer drug and others don’t?
LM Pujolras, J Cairns
Journal of Cancer Policy 4, 21-25, 2015
Another look at the comparisons of the health systems expenditure indicators
G Lopez-Casasnovas, L Maynou, M Saez
Social Indicators Research 121 (1), 149-175, 2015
What is driving HTA decision-making? Evidence from cancer drug reimbursement decisions from 6 European countries
L Maynou, J Cairns
Health Policy 123 (2), 130-139, 2019
Inclusive economic growth for health equity: in search of the elusive evidence
G López-Casasnovas, L Maynou
Reframing global social policy: Social investment for sustainable and …, 2018
Comparativa de los sistemas de evaluación de medicamentos: evidencia Europea.¿ Es necesaria una unificación de los criterios de evaluación?
L Maynou-Pujolras, G Lopez-Casasnovas
Revista Espanola de Economia de la Salud 11 (2), 158-167, 2016
An empirical analysis of Drug Reimbursement Decisions in 10 European countries
L Maynou, J Cairns
LSHTM-‐THETA Working Paper 2, 2016
Health and economic convergence in the European Union (1990-2010): an econometric approach
L Maynou Pujolràs
Universitat de Girona, 2013
Why do health technology assessment drug reimbursement recommendations differ between countries? A parallel convergent mixed methods study
E Nicod, L Maynou, E Visintin, J Cairns
Health Economics, Policy and Law. DOI:, 2019
The effects of copayment in primary health care: evidence from a natural experiment
L Maynou, G Coll‑de‑Tuero, M Saez
The European Journal of Health Economics, 2019
Exploring the Impact of New Medical Technology on Workforce Planning
L Maynou, A McGuire, V Serra-Sastre
City, University of London, 2019
Physical activity and mental health: a systematic review
L Maynou, HM Hernández-Pizarro, M Herisson, M Saez
OP49 Restrictive Versus Non-Restrictive Drug Reimbursement Systems
L Maynou
International Journal of Technology Assessment in Health Care 33 (S1), 22-23, 2017
Controlling expenditure within the Spanish pharmaceutical market: macro- and micro-level policy approaches.
M Kanavos, P., Mills, M., Cheatley, J., Lopez-Casasnovas, G., Manganelli, A ...
LSE Health, London, UK., 2017
La investigación en eficiencia hospitalaria en España
L Maynou-Pujolras
Fundación Gaspar Casal, 2017
Core Principle Meaning Evidence
DHCC Herrero, AES Jornadas, C y Jornadas, P y Condecoraciones, ...
The system can't perform the operation now. Try again later.
Articles 1–20